Calyx Acquired by CapVest/GLO Healthcare
The financial transaction details pertaining to the eClinical technology provider's deal were not disclosed.
GLO Healthcare, a healthcare platform created by private equity investor CapVest Partners LLP, has completed the acquisition of Calyx, an software and services provider of medical imaging, IRT, CTMS, RIM and EDC for the clinical trials industry. The terms of the transaction are not being disclosed. Calyx will join GLO’s development and delivery of diagnostic testing for major cancers and other diseases.
Read more about
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Related Articles
How the NIMBLE Study Supported Adherence With Quarterly Dosing of CemdisiranSeptember 18th 2025
Everything to Know About FDA’s Push Towards Radical Transparency in 2025September 17th 2025
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
